Results 361 to 370 of about 1,772,507 (392)

Immunotherapy for tuberculosis: current strategies and future directions. [PDF]

Mil Med Res
Lyu MY, Lai HL, Peng HR, Luo H, Zhou J, Ma WA, Zhang CY, Ruan HX, Liu Y, Chen J, Ying BW.   +10 more
europepmc   +1 more source

Research hotspots and trends in tumor vaccine adjuvants: A bibliometric analysis from 2010 to 2024. [PDF]

Hum Vaccin Immunother
Gong L, Lu W, Chang L, Cui Y, Zhao S.
europepmc   +1 more source

Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines. [PDF]

Nat Commun
Pesce M, Feikin DR, Higdon MM, O'Brien KL, Patel MK, Rearte A, Vizzotti C, Wilder-Smith A, Parker EPK.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Developing Covid-19 Vaccines at Pandemic Speed.

New England Journal of Medicine, 2020
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consist...
N. Lurie, M. Saville, R. Hatchett, J. Halton   +3 more
semanticscholar   +1 more source

COVID-19 vaccines

Current Opinion in Immunology, 2021
COVID-19 is a pandemic of unprecedented proportions in recent human history. Less than 18 months since the onset of the pandemic, there are close to two hundred million confirmed cases and four million deaths worldwide.
D. Ndwandwe, C. Wiysonge
semanticscholar   +1 more source

Vaccines, vaccination in Brucellosis

Annales de l'Institut Pasteur / Microbiologie, 1987
International ...
Plommet, Michel, Serre, A., Fensterbank, R.   +2 more
openaire   +4 more sources